Leslie E.  Lehmann , MD


Director, Clinical Stem Cell Transplantation Program
Office Phone: 617-632-4882
Appointment Line: 1-888-PEDI-ONC (733-4662)
Fax: 617-632-2095
NPI: 1770542359

Departments/Divisions

Specialties

hematology/oncology
hematopoietic stem cell transplantation
hematopoietic stem cell transplantation for sickle cell disease and thalassemia
late effects of transplantation
role of exercise in hematopoietic stem cell transplantation
second transplants
transplant for BM failure syndrome

Services/Programs

Academic Appointments

Assistant Professor of Pediatrics, Harvard Medical School

Certifications

Pediatric Hematology/Oncology, Pediatrics

Medical School

Duke University School of Medicine, Durham, NC

Residency

Pediatrics, Duke University School of Medicine, Durham, NC

Fellowship

Pediatric Hematology/Oncology, Children's Hospital Boston/Dana-Farber Cancer Institute, Boston, MA
Duncan CN, Vrooman L, Apfelbaum EM, Whitley K, Bechard L, Lehmann LE. 25-Hydroxy Vitamin D Deficiency Following Pediatric Hematopoietic Stem Cell Transplant. Biol Blood Marrow Transplant. 2011 May;17(5):749-53.

Lightdale JR, Randolph AG, Tran CM, Jiang H, Colon A, Houlahan K, Billet A, Sloan S, Lehmann LE. Impact of a Conservative Red Blood Cell Transfusion Strategy in Children Undergoing Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2011, Nov 11. [Epub ahead of print]

Oshrine B, Lehmann LE, Duncan CN. Safety and utility of liver biopsy after pediatric hematopoietic stem cell transplantation. J Pediatr Hematol Oncol. 2011 Apr;33(3):e92-7

Smith AR, Majhail NS, Macmillan ML, Defor TE, Jodele S, Lehmann LE, Krance R, Davies SM.Hematopoietic cell transplantation comorbidity index predicts transplant outcomes in pediatric patients. Blood. 2011, Mar 3;117(9):2728-34

  • Dana-Farber Cancer Institute
    Department of Pediatric Oncology
    450 Brookline Ave
    Boston, MA  02215
    Phone: 617-632-4882
    Fax: 617-632-2095

Other Office Location